Quick search:
Content Search
Result Content Research
Result Content Research
1 MHRA recalls contaminated Irbesartan and Losartan batches as precautionary measure
2 Following a satisfactory review, MHRA extends authorisation of NHS Test and Trace lateral flow devices
3 BRIEF-UK's MHRA Says Recalls Contaminated Irbesartan And Losartan Batches As Precautionary Measure
4 MHRA authorises Pfizer/BioNTech's COVID-19 vaccine for 12- to 15-year-olds
5 Yellow Card scheme for adverse events does not suggest any new side effects of COVID-19 vaccines
6 Amicus Therapeutics Announces United Kingdom's MHRA Grants
7 Sensyne Health appoints former MHRA boss as non-executive director
8 Euro Roundup: MHRA seeks feedback on patient engagement strategy
9 MHRA Confirms Registration of Avacta's AffiDX® SARS-CoV-2 Antigen Lateral Flow Test
10 BRIEF-UK's MHRA Concludes Positive Safety Profile For Pfizer/Biontech Vaccine In 12 To 15-Year-Olds
11 UK Food Allergy Diagnostic company, Reacta Biotech, achieves MHRA Pharma GMP accreditation
12 Sensyne Health appoints former MHRA boss as an independent director
13 One-dose Janssen COVID-19 vaccine approved by the MHRA
14 Covid-19: UK extends lateral flow test authorisation despite US warning not to use them
15 New MHRA approval for venetoclax in newly-diagnosed AML
16 Poster about Yellow Card scheme is not real
17 Urgent recall on common painkillers over fears people could overdose
18 UK ABHI Perspectives On Enabling Regulation – Part 1: Regulatory Certainty Vital For Medtechs
19 MHRA Chairman Lightfoot Ready To Lead Post-EU Agenda For UK Devices
20 Pfizer/BioNTech COVID-19 vaccine shelf-life extended from 5 to 31 days, says MHRA
21 MHRA Confirms Registration of Avacta’s AffiDX SARS-CoV-2 Antigen Lateral Flow Test
22 Over 3 million medicines and devices seized in UK as part of global crackdown
23 Fact Check-Video misinterprets data of possible adverse drug reactions reported to the Yellow Card scheme
24 Common drugs used by NHS recalled over fears of 'increased cancer risk'
25 Fact Check-More people have not died from COVID-19 vaccines than from the disease itself
26 MHRA approval for AbbVie's Acute Myeloid Leukaemia treatment option
27 BRIEF—MHRA backs Jemperli, first anti-PD-1 monotherapy for recurrent o
28 GPC lobbying MHRA to remove 15-minute observation period after Pfizer jab
29 Freedom of Information responses from the MHRA
30 EMA and MHRA validate regulatory applications for new use of Kaftrio
31 MHRA seizes £9m worth of meds as 'thousands' of fake pharmacies closed
32 EU Hits AstraZeneca Vaccine with Another Blood Condition for Side Effect List
33 First single-dose COVID-19 vaccine approved for use in UK by MHRA
34 First branded generic alternative to Fostair gets MHRA approval
35 British Airways is not in 'crisis talks' with the government about vaccinated pilots
36 MHRA approves Pfizer COVID-19 vaccine for 12- to 15-year-olds
37 COVID-19 test used in UK mass screening program receives stinging rebuke from FDA
38 Euro Roundup: EU launches survey for COVID-19 drug developers
39 UK medicine regulator looking at capillary leak syndrome precaution for AstraZeneca shot
40 Rapid Covid tests used in mass UK programme get scathing US report
41 PhaseBio (PHAS) Announces European Licensing Agreement with Alfasigma SpA for Commercialization of Bentracimab
42 Sorrento Therapeutics Inc. (NASDAQ: SRNE) Gains After MHRA Clears COVI-DROPS For Phase 2 Study
43 Proposed Patient and Public Involvement Strategy 2020-25
44 Autolus Therapeutics Announces Innovation Licensing and Access Pathway (ILAP) designation for obe-cel for the treatment of relapsed/refractory adult B-cell ALL
45 Sorrento Receives Authorization From the UK Regulatory Agency to Conduct a Phase 2 Clinical Trial for
46 UK COVID-19 Update: Vaccine Call-up for All Adults, Delta Variant Cases Surge, Pandemic Surgery Backlog 'Will Rise'
47 PhaseBio Announces European Licensing Agreement with Alfasigma SpA for Commercialization of Bentracimab
48 Avacta still waiting on MHRA approval for Covid-19 test
49 Blood pressure pills recalled: Tablets recalled due to explosive chemical
50 GBT's Voxelotor is First Sickle Cell Disease Treatment to Receive Promising Innovative Medicine (PIM) Designation in the UK
51 MHRA recalls Carbimazole10mg and 15mg tablets
52 Sensyne announces new independent non-executive director
53 Field Safety Notices: 24 to 28 May 2021
54 Sorrento Therapeutics Starts Large Efficacy Trial For Intranasal COVID-19 Antibody In UK
55 PhaseBio, Alfasigma of Italy sign licensing deal valued at up to $245M
56 Could Pharmacy Collect be at risk as FDA recalls Innova tests in US?
57 Class 2 Medicines Recall: Bristol Laboratories Limited, Brown & Burk UK Ltd, Teva UK Ltd, Irbesartan-containing and Losartan-containing products, EL (21)A/14
58 Humanigen Inc. (HGEN) Initiates Submission for Lenzilumab Marketing Authorization in COVID-19, to the United Kingdom's Medicines and Healthcare Products Regulatory Agency
59 Covid jabs for children: Parents divided on whether they would allow vaccination
60 Claims that Covid vaccine spike proteins are harmful are unevidenced
61 Biotech firm says error will not delay covid test commercialisation |
62 Websites offering medicinal treatment services – February 2021
63 More work needed to evaluate Covid tests – experts
64 Promotion of Fintepla by Zogenix International Limited
65 Man has leg amputated after suffering rare blood clot three weeks after first dose of AstraZeneca vaccine...
66 [Withdrawn] Further MHRA response to the precautionary suspensions of COVID-19 Vaccine AstraZeneca
67 Astellas' Xtandi bags additional MHRA approval in prostate cancer
68 UK medicines regulator gives approval for first UK COVID-19 vaccine
69 The MHRA and Covid vaccine approval: everything you need to know
70 UK’s MHRA says it has ‘concerns’ about Babylon Health — and flags legal gap around triage chatbots
71 AZ' Tagrisso first to win MHRA approval under Project Orbis
72 Why one in eight under-30s is concerned about getting the Covid vaccine, according to experts
73 MHRA pilot aims to boost patient involvement in clinical research
74 MHRA kicks off new accelerated drug approval pathway with 'innovation passports'
75 Register medical devices to place on the market
76 Promotion of Phynova Joint & Muscle Pain Relief Tablets (Sigesbeckia extract) on website
77 GSK's PD-1 inhibitor Jemperli approved in the UK
78 UK's MHRA Grants Early Access to AstraZeneca's Tagrisso as Adjuvant NSCLC Treatment
79 JCVI not recommending vaccinating children, minister suggests
80 Freedom of Information request on adverse reactions to COVID-19 vaccines from Northern Ireland (FOI 21-265)
81 [Withdrawn] MHRA response to Danish, Norwegian and Icelandic authorities' action to temporarily suspend the AstraZeneca COVID-19 vaccine
82 Register to make submissions to the MHRA
83 U.K.'s MHRA requires trial sponsors to assess vaccine impact
84 Euro Roundup: MHRA pilot seeks evidence of patient involvement in R&D
85 MHRA: In-person inspections to start 29 March
86 MHRA okays third COVID-19 vaccine | RAPS
87 Covid-19: Evidence does not suggest AstraZeneca jab linked to clots, MHRA says
88 MHRA Grants Promising Innovative Medicine Designation to Nirsevimab
89 MHRA approves label extension for Vertex's Kaftrio combo
90 Benefits of AZ vaccine outweigh risks, says MHRA
91 MHRA starts rolling review of AZ's coronavirus vaccine
92 MHRA green light for DemeRx's opioid use disorder trial
93 MHRA Joins the Australia-Canada-Singapore-Switzerland Consortium of Regulators
94 MHRA to fast-track vaccines modified for new COVID-19 variants
95 Letters and medicine recalls sent to healthcare professionals in May 2021
96 MHRA authorises Amarin's heart drug Vazkepa
97 MHRA awards first 'innovation passport' under new pathway
98 Promotion of Saxenda by Med Connections Limited (trading as Doctor 4 U)
99 Medical device safety information produced by the MHRA
100 UK's MHRA starts rolling review of Moderna's COVID-19 vaccine